These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23157580)

  • 21. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
    Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
    Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. DNA augments antigenicity of mycobacterial DNA-binding protein 1 and confers protection against Mycobacterium tuberculosis infection in mice.
    Matsumoto S; Matsumoto M; Umemori K; Ozeki Y; Furugen M; Tatsuo T; Hirayama Y; Yamamoto S; Yamada T; Kobayashi K
    J Immunol; 2005 Jul; 175(1):441-9. PubMed ID: 15972678
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Humoral immune response against mycobacterial antigens in patients with tuberculosis and mycobacterial infections other than tuberculosis].
    Demkow U; Białas-Chromiec B; Filewska M; Zielonka T; Michałowska-Mitczuk D; Kuś J; Broniarek-Samson B; Augustynowicz-Kopeć E; Zwolska Z; Rowińska-Zakrzewska E
    Pneumonol Alergol Pol; 2006; 74(2):203-8. PubMed ID: 17269370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased IgG1, IFN-gamma, TNF-alpha and IL-6 responses to Mycobacterium tuberculosis antigens in patients with tuberculosis are lower after chemotherapy.
    Mattos AM; Almeida Cde S; Franken KL; Alves CC; Abramo C; de Souza MA; L'Hotellier M; Alves MJ; Ferreira AP; Oliveira SC; Ottenhoff TH; Teixeira HC
    Int Immunol; 2010 Sep; 22(9):775-82. PubMed ID: 20624776
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is mycobacterial heat shock protein 16 kDa, a marker of the dormant stage of Mycobacterium tuberculosis, a sarcoid antigen?
    Dubaniewicz A; Holownia A; Kalinowski L; Wybieralska M; Dobrucki IT; Singh M
    Hum Immunol; 2013 Jan; 74(1):45-51. PubMed ID: 23079237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evolution of IGRA researches].
    Ariga H; Harada N
    Kekkaku; 2008 Sep; 83(9):641-52. PubMed ID: 18979999
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Contribution of the serum anti-mycobacterial IgG measurement to the diagnosis of tuberculosis. Personal cases].
    Chirillo MG; Daglio C; Galietti F; Ardizzi A; Barberis S; Bianco O; De Intinis G
    G Batteriol Virol Immunol; 1991; 84(1-12):97-102. PubMed ID: 1844924
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tuberculosis in elephants: antibody responses to defined antigens of Mycobacterium tuberculosis, potential for early diagnosis, and monitoring of treatment.
    Lyashchenko KP; Greenwald R; Esfandiari J; Olsen JH; Ball R; Dumonceaux G; Dunker F; Buckley C; Richard M; Murray S; Payeur JB; Andersen P; Pollock JM; Mikota S; Miller M; Sofranko D; Waters WR
    Clin Vaccine Immunol; 2006 Jul; 13(7):722-32. PubMed ID: 16829608
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The prognosis of latent tuberculosis: can disease be predicted?
    Andersen P; Doherty TM; Pai M; Weldingh K
    Trends Mol Med; 2007 May; 13(5):175-82. PubMed ID: 17418641
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical utility of a combination of lipoarabinomannan, 38-kDa, and 16-kDa antigens as a diagnosis tool for tuberculosis.
    Deng S; Yuan T; Xia J; Huang H; Cheng X; Chen M
    Diagn Microbiol Infect Dis; 2011 Sep; 71(1):46-50. PubMed ID: 21784596
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune response and protection by DNA vaccines expressing antigen 85B of Mycobacterium tuberculosis.
    Pardini M; Giannoni F; Palma C; Iona E; Cafaro A; Brunori L; Rinaldi M; Fazio VM; Laguardia ME; Carbonella DC; Magnani M; Ensoli B; Fattorini L; Cassone A
    FEMS Microbiol Lett; 2006 Sep; 262(2):210-5. PubMed ID: 16923077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MVA-85A, a novel candidate booster vaccine for the prevention of tuberculosis in children and adults.
    Nicol MP; Grobler LA
    Curr Opin Mol Ther; 2010 Feb; 12(1):124-34. PubMed ID: 20140824
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative evaluation of profiles of antibodies to mycobacterial capsular polysaccharides in tuberculosis patients and controls stratified by HIV status.
    Yu X; Prados-Rosales R; Jenny-Avital ER; Sosa K; Casadevall A; Achkar JM
    Clin Vaccine Immunol; 2012 Feb; 19(2):198-208. PubMed ID: 22169090
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative evaluation of T-cell response after specific antigen stimulation in active and latent tuberculosis infection in adults and children.
    Latorre I; De Souza-Galvão M; Ruiz-Manzano J; Lacoma A; Prat C; Fuenzalida L; Altet N; Ausina V; Domínguez J
    Diagn Microbiol Infect Dis; 2009 Nov; 65(3):236-46. PubMed ID: 19822269
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of tuberculous IgG antibodies using Mycobacterium tuberculosis H37Ra, excretory secretory antigen and tuberculin-purified protein derivative.
    Kumar S; Chenthamarakshan V; Reddy MV; Narang P; Gupta OP; Harinath BC
    Indian J Exp Biol; 1994 Mar; 32(3):163-7. PubMed ID: 8070835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diagnostic potential of Ag85C in comparison to various secretory antigens for childhood tuberculosis.
    Kumar G; Dagur PK; Singh M; Yadav VS; Dayal R; Singh HB; Katoch VM; Sengupta U; Joshi B
    Scand J Immunol; 2008 Aug; 68(2):177-83. PubMed ID: 18702747
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessing the serodiagnostic potential of 35 Mycobacterium tuberculosis proteins and identification of four novel serological antigens.
    Weldingh K; Rosenkrands I; Okkels LM; Doherty TM; Andersen P
    J Clin Microbiol; 2005 Jan; 43(1):57-65. PubMed ID: 15634951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ag85B-ESAT-6 adjuvanted with IC31® promotes strong and long-lived Mycobacterium tuberculosis specific T cell responses in volunteers with previous BCG vaccination or tuberculosis infection.
    van Dissel JT; Soonawala D; Joosten SA; Prins C; Arend SM; Bang P; Tingskov PN; Lingnau K; Nouta J; Hoff ST; Rosenkrands I; Kromann I; Ottenhoff TH; Doherty TM; Andersen P
    Vaccine; 2011 Mar; 29(11):2100-9. PubMed ID: 21256189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of a phenolglycolipid antigen (PGL-Tb 1) from M. tuberculosis in the serodiagnosis of tuberculosis: comparison with PPD antigen.
    Martín Casabona N; Gonzalez Fuente T; Arcalis Arce L; Otal Entraigas J; Vidal Pla R
    Acta Leprol; 1989; 7 Suppl 1():89-93. PubMed ID: 2504014
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monoclonal antibodies against a Mycobacterium tuberculosis Ag85B-Hsp16.3 fusion protein.
    Zhao S; Shi J; Zhang C; Zhao Y; Mao F; Yang W; Bai B; Zhang H; Shi C; Xu Z
    Hybridoma (Larchmt); 2011 Oct; 30(5):427-32. PubMed ID: 22008069
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.